These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37905042)

  • 1. Assigning credit where it's due: An information content score to capture the clinical value of Multiplexed Assays of Variant Effect.
    Ranola JMO; Horton C; Pesaran T; Fayer S; Starita LM; Shirts BH
    bioRxiv; 2023 Oct; ():. PubMed ID: 37905042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assigning credit where it is due: an information content score to capture the clinical value of multiplexed assays of variant effect.
    Ranola JMO; Horton C; Pesaran T; Fayer S; Starita LM; Shirts BH
    BMC Bioinformatics; 2024 Sep; 25(1):295. PubMed ID: 39243022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN.
    Fayer S; Horton C; Dines JN; Rubin AF; Richardson ME; McGoldrick K; Hernandez F; Pesaran T; Karam R; Shirts BH; Fowler DM; Starita LM
    Am J Hum Genet; 2021 Dec; 108(12):2248-2258. PubMed ID: 34793697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining and Reducing Variant Classification Disparities.
    Dawood M; Fayer S; Pendyala S; Post M; Kalra D; Patterson K; Venner E; Muffley LA; Fowler DM; Rubin AF; Posey JE; Plon SE; Lupski JR; Gibbs RA; Starita LM; Robles-Espinoza CD; Coyote-Maestas W; Gallego Romero I
    medRxiv; 2024 Apr; ():. PubMed ID: 38645101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal framework to resolve variants of uncertain significance in
    Biar CG; Pfeifer C; Carvill GL; Calhoun JD
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Repair Function Scores for 2172 Variants in the BRCA1 Amino-Terminus.
    Diabate M; Islam MM; Nagy G; Banerjee T; Dhar S; Smith N; Adamovich AI; Starita LM; Parvin JD
    bioRxiv; 2023 Apr; ():. PubMed ID: 37090572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reclassification of
    Ha HI; Ryu JS; Shim H; Kong SY; Lim MC
    J Gynecol Oncol; 2020 Nov; 31(6):e83. PubMed ID: 33078592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
    So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
    Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome.
    Scott A; Hernandez F; Chamberlin A; Smith C; Karam R; Kitzman JO
    Genome Biol; 2022 Dec; 23(1):266. PubMed ID: 36550560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of PTEN missense VUS through exascale simulations.
    Sinha S; Li J; Tam B; Wang SM
    Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37843401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay.
    Hu C; Susswein LR; Roberts ME; Yang H; Marshall ML; Hiraki S; Berkofsky-Fessler W; Gupta S; Shen W; Dunn CA; Huang H; Na J; Domchek SM; Yadav S; Monteiro ANA; Polley EC; Hart SN; Hruska KS; Couch FJ
    Clin Cancer Res; 2022 Sep; 28(17):3742-3751. PubMed ID: 35736817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of genomic germline variant reclassification on clinical cancer care.
    Slavin TP; Manjarrez S; Pritchard CC; Gray S; Weitzel JN
    Oncotarget; 2019 Jan; 10(4):417-423. PubMed ID: 30728895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.
    Andreis TF; de Souza KIW; Vieira IA; Alemar B; Sinigaglia M; de Araújo Rocha YM; Artigalás O; Bittar C; Oliveira Netto CB; Ashton-Prolla P; Rosset C
    Gene; 2023 Apr; 862():147281. PubMed ID: 36775216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-objective prioritization of genes for high-throughput functional assays towards improved clinical variant classification.
    Chen Y; Jain S; Zeiberg D; Iakoucheva LM; Mooney SD; Radivojac P; Pejaver V
    Pac Symp Biocomput; 2023; 28():323-334. PubMed ID: 36540988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.
    Kim JJ; Kim DJ; Nam EJ; Song KE; Ham JY; Kim YK; Lee NY
    Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing.
    Chen E; Facio FM; Aradhya KW; Rojahn S; Hatchell KE; Aguilar S; Ouyang K; Saitta S; Hanson-Kwan AK; Capurro NN; Takamine E; Jamuar SS; McKnight D; Johnson B; Aradhya S
    JAMA Netw Open; 2023 Oct; 6(10):e2339571. PubMed ID: 37878314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots".
    Dines JN; Shirts BH; Slavin TP; Walsh T; King MC; Fowler DM; Pritchard CC
    Genet Med; 2020 May; 22(5):825-830. PubMed ID: 31911673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prioritizing genes for systematic variant effect mapping.
    Kuang D; Truty R; Weile J; Johnson B; Nykamp K; Araya C; Nussbaum RL; Roth FP
    Bioinformatics; 2021 Apr; 36(22-23):5448-5455. PubMed ID: 33300982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic, Surgical and Oncological Approach to Breast Cancer, with
    Subaşıoğlu A; Güç ZG; Gür EÖ; Tekindal MA; Atahan MK
    Eur J Breast Health; 2023 Jan; 19(1):55-69. PubMed ID: 36605468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of 2,832 JAG1 variants supports reclassification for Alagille syndrome and improves guidance for clinical variant interpretation.
    Gilbert MA; Keefer-Jacques E; Jadhav T; Antfolk D; Ming Q; Valente N; Shaw GT; Sottolano CJ; Matwijec G; Luca VC; Loomes KM; Rajagopalan R; Hayeck TJ; Spinner NB
    Am J Hum Genet; 2024 Aug; 111(8):1656-1672. PubMed ID: 39043182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.